Future theranostic strategies: emerging ovarian cancer biomarkers to bridge the gap between diagnosis and treatment
Article in Frontiers in Drug Delivery (February 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer
Article in BMC Women's Health (January 2024)
Identifying Explainable Machine Learning Models and a Novel SFRP2+ Fibroblast Signature as Predictors for Precision Medicine in Ovarian Cancer
Article in International Journal of Molecular Sciences (November 2023)